ArticleAnnals of the rheumatic diseases2021

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19.

Alessia Alunno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.